recentpopularlog in

jerryking : biotech   5

Canada 200: How to build a business superpower by 2067
Ottawa's upcoming IP strategy should include training for academics, entrepreneurs and administrators about the strategic importance of patents. But those same players must also collectively push to create global standards for technologies developed here. Other countries, including China and the United States, effectively ensure new global standards incorporate their homegrown technology, locking in value for their emerging champions. Canada, by comparison, is a "boy scout," says Michel Girard, vice-president of the Standards Council of Canada.
Artic  biotech  Canada  cannabis  cleantech  Colleges_&_Universities  digital_economy  elitism  gender_gap  infrastructure  intellectual_property  life_sciences  patents  ports  technical_standards  universal_basic_income  uToronto  Vancouver  women 
july 2017 by jerryking
M.I.T. Lab Hatches Ideas, and Companies, by the Dozens - NYTimes.com
November 24, 2012 | NYT | By HANNAH SELIGSON.

Dr. Robert Langer, 64, knows how. Since the 1980s, his Langer Lab at the Massachusetts Institute of Technology has spun out companies whose products treat cancer, diabetes, heart disease and schizophrenia, among other diseases, and even thicken hair.

The Langer Lab is on the front lines of turning discoveries made in the lab into a range of drugs and drug delivery systems. Without this kind of technology transfer, the thinking goes, scientific discoveries might well sit on the shelf, stifling innovation.

A chemical engineer by training, Dr. Langer has helped start 25 companies and has 811 patents, issued or pending, to his name.
MIT  Colleges_&_Universities  entrepreneur  entrepreneurship  start_ups  technology_transfers  scaling  mentoring  biotech  pharmaceutical_industry  innovation  academia  commercialization  accelerators  incubators 
november 2012 by jerryking
The Rise of Backyard Biotech - Magazine - The Atlantic
JUNE 2011 ATLANTIC MAGAZINE
The Rise of Backyard Biotech
Powered by social networking, file sharing, and e-mail, a new cottage industry is bringing niche drugs to market.

By QUINN NORTON
innovation  biotech  home_based  DIY  medical  pharmaceutical_industry  cottage_industries  drug_development 
may 2011 by jerryking
Long & Short - WSJ.com
* JULY 19, 2006

Irascible Analyst Gives Up Fight
Evan Sturza Went His Own Way On Biotech Stocks for 15 Years; He Leaves, Independent to the Last

*
By JESSE EISINGER
biotech  integrity  analysts  stock_picking 
may 2009 by jerryking

Copy this bookmark:





to read